SME Times is powered by   
Search News
Just in:   • Indian equity indices end slightly lower ahead of RBI's MPC outcome  • J&K’s Kishtwar selected as aspirational agricultural district under PMDDKY  • Indian stock market opens higher as RBI MPC begins  • Mumbai-Ahmedabad bullet train to be fully operational by 2029: Ashwini Vaishnaw  • Nifty, Sensex see sharp decline this week amid H-1B, pharma tariff concerns 
Last updated: 27 Sep, 2014  

Launch of IBEF Publication - The Best of India in Pharmaceuticals

PR Newswire | 11 Oct, 2012
Launch of IBEF Publication 'The Best of India in Pharmaceuticals' at Innovation Awards, CPhI Worldwide

MADRID and GURGAON, India: The India Brand Equity Foundation (IBEF) publication titled 'The Best of India in Pharmaceuticals' was released last evening at the Innovation Awards at CPhI Worldwide by Mr S R Rao, Commerce Secretary, Ministry of Commerce and Industry, Government of India, Mr Nik Rudge, Managing Director, UBM Live and Mr Andrew Pert, Brand Director, UBM Live.

Innovation Awards, a platform to recognise, celebrate and honour companies that are breaking new ground in the pharmaceutical industry by CPhI, provided a perfect platform for the release of this publication that covers the growth of the Indian pharmaceutical industry and at the same time, talks about the recent innovations by the Indian companies in the pharma space.

With a brief overview of the Indian pharmaceutical industry, the coffee table book talks about the current scenario in various segments of the Indian pharmaceutical market and opportunities available in the industry.

"The Best of India in Pharmaceuticals, highlighting the changing dynamics of the Indian pharmaceutical market, talks about the various opportunities available in domestic as well as the exports market. At the same time, the publication also covers the government initiatives as well as the regulatory framework of India, making it a must-have for every company interested in the Indian pharmaceutical industry across the globe," said Aparna Dutt Sharma, Chief Executive Officer, IBEF.

Divided into 10 detailed chapters covering all the broad segments of the Indian pharma sector like Biotechnology, Clinical Trials, Biosimilars, Probiotics, Neutraceuticals and Contract Manufacturing, the publication aims to highlight the strength of the Indian pharma sector and the key opportunities available across segments.

About The India Brand Equity Foundation (IBEF)

India Brand Equity Foundation is a Trust established by the Ministry of Commerce with the Confederation of Indian Industry (CII) as its associate. IBEF's primary objective is to promote and create international awareness of the Made in India label in markets overseas and to facilitate the dissemination of knowledge of Indian products and services. IBEF is engaged in building Brand India. Towards this objective IBEF works closely with stakeholders across government and industry.

For more information on Events, please visit http://www.brandindiapharma.in/event/

Primary Media Contact: Aditi Thakur, aditi.thakur@ibef.org, 91-9818143259

Secondary Media Contact: Pawan Chabra, pawan.chabra@ibef.org, 91-124-4499609

 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹84.00
₹82.25
UK Pound
₹104.65
₹108.10
Euro
₹92.50
₹89.35
Japanese Yen ₹56.10 ₹54.40
As on 25 Jul, 2025
  Daily Poll
Who do you think will benefit more from the India - UK FTA in the long run?
 Indian businesses & consumers.
 UK businesses & consumers.
 Both will gain equally.
 The impact will be negligible for both.
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter